Profile data is unavailable for this security.
About the company
JIANMIN PHARMACEUTICAL GROUP CO., LTD., formerly Wuhan Jianmin Pharmaceutical Groups Co. Ltd, is a China-based company, principally engaged in the research and development, manufacture, wholesale and retailing of pharmaceuticals. The Company operates its businesses through two segments, including Pharmaceutical Industry and Pharmaceutical Business. The Pharmaceutical Industry segment is engaged in the research and development and manufacture of pharmaceuticals. Its products are mainly applied in children, women and the elderly, among others. The Pharmaceutical Business segment is engaged in the wholesale and retailing of pharmaceuticals. Its products include traditional Chinese medicine, Western medicine, health products, medical equipment and chemical agents. It distributes its products mainly in domestic market.
- Revenue in CNY (TTM)3.98bn
- Net income in CNY427.95m
- Incorporated1993
- Employees2.50k
- LocationJianmin Pharmaceutical Group Co LtdNo.484 Yingwu Avenue, Hanyang DistrictWUHAN 430052ChinaCHN
- Phone+86 2 784523350
- Fax+86 2 784523350
- Websitehttp://www.whjm.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cisen Pharmaceutical Co Ltd | 4.25bn | 529.01m | 6.45bn | 3.40k | 12.18 | 1.11 | -- | 1.52 | 1.17 | 1.17 | 9.41 | 12.89 | 0.585 | 2.15 | 6.06 | 1,250,659.00 | 7.33 | 6.94 | 9.10 | 8.56 | 57.72 | 56.27 | 12.53 | 10.77 | 2.63 | -- | 0.0329 | 33.42 | 9.75 | 3.22 | 48.92 | 0.697 | -15.19 | 10.72 |
| Jianmin Pharmaceutical Group Co Ltd | 3.98bn | 427.95m | 6.70bn | 2.50k | 15.61 | 2.80 | -- | 1.68 | 2.80 | 2.80 | 25.98 | 15.61 | 0.9793 | 6.99 | 4.16 | 1,592,652.00 | 10.62 | 10.87 | 18.49 | 19.11 | 42.34 | 43.04 | 10.84 | 9.32 | 1.38 | -- | 0.1492 | 37.15 | 15.72 | 14.28 | 27.78 | 45.05 | 8.77 | 43.10 |
| Sichuan Huiyu Pharmaceutical Co Ltd | 1.12bn | 278.20m | 6.82bn | 1.36k | 24.52 | 1.76 | -- | 6.09 | 0.6567 | 0.6567 | 2.64 | 9.16 | 0.2335 | 1.18 | 21.25 | 820,954.90 | 5.66 | 10.41 | 7.08 | 12.76 | 83.40 | 89.89 | 24.23 | 21.42 | 2.57 | -- | 0.1488 | 20.54 | -37.92 | 76.37 | -43.86 | -- | 66.72 | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 691.62m | 105.20m | 6.90bn | 948.00 | 85.74 | 3.77 | -- | 9.97 | 0.0998 | 0.0998 | 0.6509 | 2.27 | 0.2482 | 1.53 | 1.50 | 729,558.10 | 3.76 | 7.03 | 4.43 | 9.05 | 90.24 | 92.17 | 15.15 | 17.26 | 6.06 | -- | 0.0048 | 26.31 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | -- |
| Wuhan Keqian Biology Co Ltd | 902.14m | 299.11m | 6.92bn | 923.00 | 23.19 | 1.79 | -- | 7.67 | 0.6404 | 0.6404 | 1.93 | 8.28 | 0.1968 | 2.44 | 2.47 | 977,402.10 | 6.51 | 13.29 | 7.62 | 15.49 | 63.87 | 76.49 | 33.08 | 45.71 | 4.71 | -- | 0.0209 | 24.76 | 6.27 | 7.67 | -3.32 | 0.3556 | 27.17 | -- |
| Lushang Freda Pharmaceutical Co Ltd | 3.99bn | 236.52m | 6.93bn | 3.65k | 29.31 | 1.70 | -- | 1.74 | 0.2327 | 0.2327 | 3.92 | 4.02 | 0.4694 | 0.7941 | 7.74 | 1,091,879.00 | 3.23 | 0.6992 | 5.93 | 5.12 | 48.73 | 20.23 | 6.87 | 3.45 | 2.96 | -- | 0.0896 | 40.33 | -64.65 | -12.29 | 567.44 | 13.36 | 44.40 | 14.87 |
| Zhejiang Ausun Pharmaceutical Co Ltd | 835.23m | 257.55m | 7.00bn | 1.17k | 27.10 | 3.05 | -- | 8.38 | 0.3111 | 0.3111 | 1.01 | 2.76 | 0.2788 | 1.09 | 2.84 | 711,439.10 | 8.60 | 9.38 | 11.35 | 12.84 | 54.34 | 53.09 | 30.84 | 27.14 | 2.00 | -- | 0.156 | 23.53 | 6.83 | 27.35 | 7.87 | 42.07 | 24.32 | 50.48 |
| JiangSu WuZhong Pharmactcl Devlpm Co Ltd | 2.38bn | -37.82m | 7.00bn | 1.05k | -- | 3.90 | -- | 2.94 | -0.055 | -0.055 | 3.34 | 2.52 | 0.5684 | 17.73 | 2.04 | 2,270,402.00 | -0.8772 | -2.92 | -1.79 | -5.30 | 28.07 | 28.14 | -1.54 | -5.77 | 1.46 | 0.5127 | 0.4841 | -- | 10.55 | 5.65 | 5.58 | -- | -19.08 | -- |
| China Animal Husbandry Industry Co., Ltd | 5.43bn | 87.90m | 7.02bn | 4.33k | 79.82 | 1.28 | -- | 1.29 | 0.0861 | 0.0861 | 5.31 | 5.37 | 0.6127 | 4.56 | 3.76 | 1,254,216.00 | 0.7085 | 6.23 | 1.00 | 9.01 | 16.42 | 24.29 | 1.16 | 8.69 | 1.54 | -- | 0.1909 | 31.20 | -8.24 | 4.04 | -26.73 | -0.6127 | 24.20 | -3.77 |
Data as of Nov 05 2024. Currency figures normalised to Jianmin Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
15.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 6.25m | 4.10% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 5.81m | 3.81% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 2.63m | 1.72% |
| Fullgoal Fund Management Co., Ltd.as of 30 Sep 2023 | 2.39m | 1.57% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 1.80m | 1.18% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 1.13m | 0.74% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 1.08m | 0.71% |
| Galaxy Asset Management Co., Ltd.as of 30 Jun 2024 | 958.00k | 0.63% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 721.00k | 0.47% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 617.78k | 0.41% |
More ▼
Data from 30 Jun 2024 - 27 Sep 2024Source: FactSet Research Systems Inc.
